» Articles » PMID: 25314080

Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer Via Cross-talk with Hepatocytes

Abstract

Hepatocellular carcinoma (HCC), the fastest rising cancer in the United States and increasing in Europe, often occurs with nonalcoholic steatohepatitis (NASH). Mechanisms underlying NASH and NASH-induced HCC are largely unknown. We developed a mouse model recapitulating key features of human metabolic syndrome, NASH, and HCC by long-term feeding of a choline-deficient high-fat diet. This induced activated intrahepatic CD8(+) T cells, NKT cells, and inflammatory cytokines, similar to NASH patients. CD8(+) T cells and NKT cells but not myeloid cells promote NASH and HCC through interactions with hepatocytes. NKT cells primarily cause steatosis via secreted LIGHT, while CD8(+) and NKT cells cooperatively induce liver damage. Hepatocellular LTβR and canonical NF-κB signaling facilitate NASH-to-HCC transition, demonstrating that distinct molecular mechanisms determine NASH and HCC development.

Citing Articles

Hepatic Deletion of Carbohydrate Response Element Binding Protein Impairs Hepatocarcinogenesis in a High-Fat Diet-Induced Mouse Model.

Karim M, Prey J, Willer F, Leiner H, Yasser M, Dombrowski F Int J Mol Sci. 2025; 26(5).

PMID: 40076869 PMC: 11900174. DOI: 10.3390/ijms26052246.


CAT and CXCL8 are crucial cofactors for the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma, the immune infiltration and prognosis of hepatocellular carcinoma.

Yang L, Li P, Zhao J, Bai Z, Zeng G, Liu X Discov Oncol. 2025; 16(1):272.

PMID: 40053253 PMC: 11889291. DOI: 10.1007/s12672-025-02051-y.


Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease.

Biagioli M, Fiorucci S Liver Res. 2025; 5(3):119-141.

PMID: 39957845 PMC: 11791866. DOI: 10.1016/j.livres.2021.08.003.


S-Adenosylmethionine: A Multifaceted Regulator in Cancer Pathogenesis and Therapy.

Fernandez-Ramos D, Lopitz-Otsoa F, Lu S, Mato J Cancers (Basel). 2025; 17(3).

PMID: 39941901 PMC: 11816870. DOI: 10.3390/cancers17030535.


Development of a Novel four-gene Model for Monitoring the Progression from Metabolic Dysfunction-associated Steatotic Liver Disease to Hepatocellular Carcinoma in Males.

Jiang Y, Chen J, Xu L, Lv L, Gan X J Cancer. 2025; 16(3):917-931.

PMID: 39781352 PMC: 11705051. DOI: 10.7150/jca.100724.